ICON plc, (NASDAQ: ICLR) a world-leading clinical research organisation powered by healthcare intelligence, today announced ...

ICON's 2025 revenue guidance is $8.05 billion–$8.65 billion, a 1% growth midpoint, versus consensus $8.5 billion. Adjusted EPS for 2025 is forecasted at $13.00–$15.00, flat compared to 2024 ...

ICON plc, (NASDAQ: ICLR) a world-leading healthcare intelligence and clinical research organisation, has been honoured with numerous awards in the second half of 2024. On TIME Magazine’s 2024 ...

We recently published a list of 10 AI News and Ratings Too Important to Miss. In this article, we are going to take a look at ...

ICON plc, (NASDAQ: ICLR) a world-leading clinical research organisation powered by healthcare intelligence, today announced the expansion of its portfolio of artificial intelligence (AI ...

Shares tumbled over 10%, leading a chip sell-off as China's new AI model prompted fresh questions on Big Tech's investments.

Baron Funds, an investment management company, released its “Baron Small Cap Fund” fourth-quarter 2024 investor letter. A ...

Tears represent a clinical entity for some tendons which is distinct from tendinopathy, and which may require different management to that of tendinopathy. The ICON group defined tears as a ...

ICON plc, a clinical research organization, expanded its portfolio of artificial intelligence (AI) tools that aim to deliver efficiencies across the clinical trial process, including study startup, ...